Cargando…
BMP9‐ID1 signaling promotes EpCAM‐positive cancer stem cell properties in hepatocellular carcinoma
The malignant nature of hepatocellular carcinoma (HCC) is closely related to the presence of cancer stem cells (CSCs). Bone morphologic protein 9 (BMP9), a member of the transforming growth factor‐beta (TGF‐β) superfamily, was recently reported to be involved in liver diseases including cancer. We a...
Autores principales: | Chen, Han, Nio, Kouki, Yamashita, Taro, Okada, Hikari, Li, Ru, Suda, Tsuyoshi, Li, Yingyi, Doan, Phuong Thi Bich, Seki, Akihiro, Nakagawa, Hidetoshi, Toyama, Tadashi, Terashima, Takeshi, Iida, Noriho, Shimakami, Tetsuro, Takatori, Hajime, Kawaguchi, Kazunori, Sakai, Yoshio, Yamashita, Tatsuya, Mizukoshi, Eishiro, Honda, Masao, Kaneko, Shuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333780/ https://www.ncbi.nlm.nih.gov/pubmed/33834612 http://dx.doi.org/10.1002/1878-0261.12963 |
Ejemplares similares
-
BMP9-ID1 Signaling Activates HIF-1α and VEGFA Expression to Promote Tumor Angiogenesis in Hepatocellular Carcinoma
por: Chen, Han, et al.
Publicado: (2022) -
Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma
por: Hayashi, Takehiro, et al.
Publicado: (2017) -
Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis
por: Suda, Tsuyoshi, et al.
Publicado: (2020) -
FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition
por: Li, Ru, et al.
Publicado: (2022) -
Plasma Antithrombin III Levels Can Be a Prognostic Factor in Liver Cirrhosis Patients with Portal Vein Thrombosis
por: Suda, Tsuyoshi, et al.
Publicado: (2023)